TLSI — TriSalus Life Sciences Share News
0.000.00%
Last trade - 00:00- $225.36m
- $212.14m
- $45.15m
Brief: TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
Advisory: Dated alert on Trisalus Life Sciences entering credit agreement withdrawn
Brief: Trisalus Life Sciences Announces Key Appointments To Board Of Directors
Brief: Trisalus Announces Leadership Changes
Brief: TriSalus Life Sciences Announces Appointment Of Riad Salem, M.D., To Its Scientific Advisory Board
Brief: TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial
Brief: Trisalus Life Sciences Inc On May 6, Board Increased Size Of Board To Ten Directors
Brief: Trisalus Life Sciences Appoints Liselotte Hyveled To Its Board Of Directors
Brief: TriSalus Life Sciences Secures Up To $50 Mln Of Debt Financing With Orbimed
Brief: Trisalus Life Sciences Inc Files Non-Timely 10-K With SEC
Brief: Trisalus Life Sciences Inc- Full Year 2024 Sales Growth Expected To Exceed 50%
Brief: Trisalus Life Sciences Files Prospectus Relates To Offer Upto 5.9 Mln Shares Of Common Stock
Brief: Trisalus Life Sciences Declares CMS Reimbursement For Trinav Infusion System
Brief: TriSalus Life Sciences Appoints Jodi Devlin As President Of TriSalus Therapeutics
Brief: Unique Diamond Investments Limited Reports 5.9% Passive Stake In Trisalus Life Sciences Inc As Of Aug 10 - SEC Filing
Brief: Lombard International Assurance Reports 5.16% Passive Stake In Trisalus Life Sciences As Of Aug 10
Brief: Medtech Acquisition Corp Adjourns Special Meeting Of Stockholders
Brief: MedTech Acquisition Corp Receives Deficiency Letter Of Non-Compliance From Nasdaq
Brief: Trisalus Life Sciences To Become Publicly Traded Through Merger